Surrozen Awarded NIH Grant to Support Development of SZN-043, a Liver-Specific Regenerative Antibody, for the Treatment of Severe Alcoholic Hepatitis
15 oct. 2020 07h00 HE
|
Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, has been awarded an NIH grant to...
Surrozen Expands Board of Directors with Appointment of David J. Woodhouse, Ph.D.
25 sept. 2020 07h00 HE
|
Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced the addition of...
Surrozen to Present at Morgan Stanley 18th Annual Global Healthcare Conference
16 sept. 2020 07h00 HE
|
Surrozen, Inc.
-- Craig Parker, CEO of Surrozen, to present Surrozen’s advancements in regenerative medicine -- SOUTH SAN FRANCISCO, Calif., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology...
Surrozen Announces Publication of Second Antibody Platform Technology in Scientific Reports
19 août 2020 10h00 HE
|
Surrozen, Inc.
-- Novel approach to creating R-spondin-mimetics establishes proof-of-concept for targeted regenerative antibodies -- SOUTH SAN FRANCISCO, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc.,...
UPDATE -- Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials
19 juin 2020 10h00 HE
|
Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced the successful...
Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trials
19 juin 2020 07h00 HE
|
Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced the successful...
Surrozen Announces Publication of Two Abstracts Providing Evidence for Liver-Targeted Tissue Regeneration
04 mai 2020 10h00 HE
|
Surrozen, Inc.
-- Abstracts originally accepted for 2020 Digestive Disease Week Conference – to be published online -- SOUTH SAN FRANCISCO, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a...
Surrozen Scientific Founder Roel Nusse, PhD Receives Prestigious Canada Gairdner International Award for Biomedical Research
06 avr. 2020 10h00 HE
|
Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., April 06, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies, today announced that one of its...
Surrozen Announces Publication of Antibody Platform Technology in Cell Chemical Biology
30 mars 2020 13h42 HE
|
Surrozen, Inc.
-- Novel approach to creating Wnt-mimetics establishes proof-of-concept for targeted regenerative antibodies -- SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a...
Surrozen to Present at Cowen and Company 40th Annual Health Care Conference
02 mars 2020 10h00 HE
|
Surrozen, Inc.
SOUTH SAN FRANCISCO, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- Surrozen, Inc., a biotechnology company pioneering a new class of targeted regenerative antibodies to repair a broad range of tissues,...